Farrow Financial’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $837K | Sell |
17,212
-144
| -0.8% | -$7K | 0.51% | 40 |
|
|
2025
Q1 | $591K | Sell |
17,356
-2,741
| -14% | -$93.3K | 0.4% | 42 |
|
|
2024
Q4 | $777K | Buy |
20,097
+270
| +1% | +$10.4K | 0.5% | 40 |
|
|
2024
Q3 | $931K | Buy |
19,827
+2,467
| +14% | +$116K | 0.59% | 39 |
|
|
2024
Q2 | $938K | Buy |
17,360
+341
| +2% | +$18.4K | 0.64% | 39 |
|
|
2024
Q1 | $1.16M | Sell |
17,019
-1,901
| -10% | -$130K | 0.81% | 41 |
|
|
2023
Q4 | $1.18M | Buy |
+18,920
| New | +$1.18M | 0.89% | 38 |
|